We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$36.5B
AUM Growth
+$3.93B
Cap. Flow
+$651M
Cap. Flow %
1.78%
Top 10 Hldgs %
7.68%
Holding
3,587
New
780
Increased
747
Reduced
671
Closed
866

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$223M
2
TJX icon
TJX Companies
TJX
+$191M
3
TDG icon
TransDigm Group
TDG
+$157M
4
IR icon
Ingersoll Rand
IR
+$155M
5
BP icon
BP
BP
+$152M

Sector Composition

Rank Sector Weight
1 Industrials 11.39%
2 Financials 11.28%
3 Technology 9.98%
4 Consumer Discretionary 9.35%
5 Healthcare 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARI
2726
PUT
Apollo Commercial Real Estate
ARI
$883M
-710,000
Closed -$5.89M
ARKK icon
2727
ARK Innovation ETF
ARKK
$6.41B
-45,442
Closed -$1.62M
ARKO icon
2728
ARKO Corp
ARKO
$530M
-15,866
Closed -$149K
AROC icon
2729
Archrock
AROC
$5.38B
-171,887
Closed -$1.1M
ARWR icon
2730
CALL
Arrowhead Research
ARWR
$12.3B
-50,000
Closed -$1.65M
ASHR icon
2731
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
-94,907
Closed -$2.58M
ATAI icon
2732
AtaiBeckley Inc
ATAI
$2.74B
-29,915
Closed -$99K
LONA
2733
LeonaBio Inc
LONA
$72.8M
-1,252
Closed -$37K
ATHM icon
2734
Autohome
ATHM
$2.52B
-140,101
Closed -$4.03M
ATRA icon
2735
Atara Biotherapeutics
ATRA
$95M
-2,339
Closed -$221K
OPTU
2736
Optimum Communications Inc
OPTU
$328M
-1,324,026
Closed -$7.72M
AUPH icon
2737
CALL
Aurinia Pharmaceuticals
AUPH
$2.2B
-130,000
Closed -$978K
AUR icon
2738
Aurora
AUR
$11.4B
-112,621
Closed -$249K
AVAV icon
2739
AeroVironment
AVAV
$7.53B
-29,653
Closed -$2.47M
AVNS
2740
DELISTED
Avanos Medical
AVNS
-30,836
Closed -$672K
AX icon
2741
Axos Financial
AX
$5.5B
-12,519
Closed -$429K
AXSM icon
2742
PUT
Axsome Therapeutics
AXSM
$10.8B
-40,000
Closed -$1.78M
AZO icon
2743
PUT
AutoZone
AZO
$49.1B
-500
Closed -$1.07M
BABA icon
2744
PUT
Alibaba
BABA
$284B
-11,500
Closed -$920K
BBIO icon
2745
CALL
BridgeBio Pharma
BBIO
$15.8B
-25,000
Closed -$249K
BCRX icon
2746
BioCryst Pharmaceuticals
BCRX
$2.47B
-1,223,721
Closed -$15.4M
BCS icon
2747
Barclays
BCS
$90.7B
-3,822,683
Closed -$24.5M
BDX icon
2748
PUT
Becton Dickinson
BDX
$52B
-26,000
Closed -$5.79M
BE icon
2749
Bloom Energy
BE
$60.1B
-446,448
Closed -$8.92M
BEN icon
2750
Franklin Templeton
BEN
$17.6B
-1,266,637
Closed -$27.3M

Similar funds

Dmitry Balyasny's Q4 2022 Portfolio in Review

As of Q4 2022, Dmitry Balyasny held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Dmitry Balyasny's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

  • Dmitry Balyasny's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
  • Dmitry Balyasny added most to Visa in Q4 2022, an estimated $223M increase.
  • Dmitry Balyasny's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
  • Dmitry Balyasny fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
  • Dmitry Balyasny's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
  • Dmitry Balyasny opened 780 new positions and closed 866 in Q4 2022.
  • Dmitry Balyasny's portfolio value rose 12% quarter-over-quarter to $36.5B.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.